Risk factor analysis for linezolid-associated thrombocytopenia in critically ill patients
Risk factor analysis for linezolid-associated thrombocytopenia in critically ill patients
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Linezolid is an antibiotic used against gram-positive bacteria, including methicillin-resistant
Staphylococcus aureus.
Its primary adverse effect is haematotoxicity. The objective of this study was to analyse the risk factors for onset of thrombocytopenia in critically ill patients treated with linezolid. This was a retrospective, single-cent...
Alternative Titles
Full title
Risk factor analysis for linezolid-associated thrombocytopenia in critically ill patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2328750292
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2328750292
Other Identifiers
ISSN
0934-9723
E-ISSN
1435-4373
DOI
10.1007/s10096-019-03754-1
